SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-100744
Filing Date
2024-11-21
Accepted
2024-11-21 09:00:14
Documents
15
Period of Report
2024-11-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0222038-8k_avalon.htm   iXBRL 8-K 37256
2 PRESS RELEASE OF THE COMPANY DATED NOVEMBER 21, 2024 ea022203801ex99-1_avalon.htm EX-99.1 8671
3 GRAPHIC ex99-1_001.jpg GRAPHIC 9777
  Complete submission text file 0001213900-24-100744.txt   237550

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE albt-20241119.xsd EX-101.SCH 3039
5 XBRL LABEL FILE albt-20241119_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE albt-20241119_pre.xml EX-101.PRE 22375
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0222038-8k_avalon_htm.xml XML 3687
Mailing Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728
Business Address 4400 ROUTE 9 SUITE 3100 FREEHOLD NJ 07728 732-780-4400
Avalon GloboCare Corp. (Filer) CIK: 0001630212 (see all company filings)

IRS No.: 471685128 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38728 | Film No.: 241482280
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)